Anzeige
Mehr »
Montag, 03.11.2025 - Börsentäglich über 12.000 News
Der menschliche Genius hinter den Maschinen: Telescope Innovations und der Aufstieg der autonomen Wissenschaft
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A2PGAF | ISIN: CA65347A1021 | Ticker-Symbol: L0MA
Frankfurt
31.10.25 | 08:00
0,033 Euro
-1,49 % -0,001
Branche
Pharma
Aktienmarkt
Sonstige
1-Jahres-Chart
NEXTLEAF SOLUTIONS LTD Chart 1 Jahr
5-Tage-Chart
NEXTLEAF SOLUTIONS LTD 5-Tage-Chart
RealtimeGeldBriefZeit
0,0320,04202.11.

Aktuelle News zur NEXTLEAF SOLUTIONS Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
12.09.Nextleaf Solutions Ltd: Nextleaf sued by former CEO Pedersen2
11.09.Nextleaf Solutions Ltd.: Nextleaf Provides Strategic Update: Canada's First 200-Pack Cannabis Softgels, and Opening of Distribution Facility314Vancouver, British Columbia--(Newsfile Corp. - September 11, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life...
► Artikel lesen
29.08.Nextleaf Solutions reports Q3 results1
28.08.Nextleaf Solutions reports fourth consecutive profitable quarter1
28.08.Nextleaf Solutions Ltd.: Nextleaf Reports Third Quarter FY25 Results Including Fourth Consecutive Profitable Quarter207Vancouver, British Columbia--(Newsfile Corp. - August 28, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life science...
► Artikel lesen
30.05.Nextleaf Solutions Ltd.: Nextleaf Reports Profitable Second Quarter FY25 Results Including Increased Revenue Growth and Positive Net Income Improvement379Vancouver, British Columbia--(Newsfile Corp. - May 30, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life science...
► Artikel lesen
15.05.Nextleaf expands national footprint with Québec market entry1
NEXTLEAF SOLUTIONS Aktie jetzt für 0€ handeln
15.05.Nextleaf Solutions Ltd.: Nextleaf Shares Commercial Update Featuring Market Expansion Through Entry into Province of Quebec187Vancouver, British Columbia--(Newsfile Corp. - May 15, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life sciences...
► Artikel lesen
04.03.Nextleaf Solutions Ltd.: Nextleaf Reports First Quarter Results for Fiscal Year 2025 Including Increased Gross Profit, and Significant Net Income Improvement222Vancouver, British Columbia--(Newsfile Corp. - March 4, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life sciences...
► Artikel lesen
29.01.Nextleaf Solutions Ltd.: Nextleaf Reports Fiscal Year 2024 Financial Performance, Achieves Record Growth from Branded Product Sales, and Maintains Debt-Free Status362Vancouver, British Columbia--(Newsfile Corp. - January 29, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), an innovation-driven life sciences...
► Artikel lesen
20.01.Nextleaf Solutions Ltd.: Nextleaf to Host Live Webinar, Featuring Canadian Cannabis Industry Trends and Insights481Vancouver, British Columbia--(Newsfile Corp. - January 20, 2025) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a leading life science firm...
► Artikel lesen
23.12.24Nextleaf Solutions Ltd.: Nextleaf Shares a Commercial Update Including 14 New Product Listings, and Announces Date for Annual General Meeting530Vancouver, British Columbia--(Newsfile Corp. - December 23, 2024) - Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (FSE: L0MA) ("Nextleaf", "OILS", or the "Company"), a leading life science firm...
► Artikel lesen
12 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1